A comprehensive guide to polycystic ovary syndrome, from a leading authority on the condition
Release Date: March 21, 2006
Click here to pre-order A Patient's Guide to PCOS
from Amazon.com.
This title will be released on March 21, 2006. You may order it now and Amazon.com will ship it to you when it arrives. Ships from and sold by Amazon.com.
A comprehensive guide to polycystic ovary syndrome, from a leading authority on the condition
One in ten American women of childbearing age is affected by polycystic ovary syndrome (PCOS) to some degree, and many suffer from serious symptoms, such as infertility, early miscarriage, chronic pelvic pain, weight gain, high blood pressure, acne, and abnormal hair growth. PCOS is by far the most common hormone imbalance in women of this age group, yet few women understand the threat it poses to their health-or how to prevent it.
In A Patient’s Guide to PCOS, Dr. Walter Futterweit, a foremost authority on PCOS in America, tells women everything they need to know about this condition and how to treat it. Drawing on his twenty-five years researching and treating the condition and his ongoing long-term study of more than a thousand women with PCOS, Futterweit discusses
This comprehensive guide contains everything women need to know about PCOS-from identifying warning signs and seeking a diagnosis to finding emotional support in recovery-to regain their health and resume their lives.
About the Author
In addition to serving as a valued member of the OBGYN.net PCOS Pavilion Editorial Advisory Board, Walter Futterweit, MD, FACE, FACP, is co-chief of the Endocrine Clinic and Clinical Professor of Medicine at Mount Sinai School of Medicine in New York City. Author of more than 100 papers and numerous textbook chapters, he lectures regularly before lay and professional groups, conducts ongoing research about PCOS, and maintains a private practice in Manhattan focused on PCOS. He is married and lives in New York City.
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
Metabolomics and proteomics linked to female infertility
January 30th 2024Dive into the latest research in metabolomics and proteomics, revealing potential biomarkers like fibrinogen cleavage peptides and GRAM domain-containing protein 1C, offering new avenues for diagnosis and treatment in addressing the global issue of female infertility.
Read More